首页> 美国卫生研究院文献>other >A Locked Nucleic Acid (LNA)-Based Real-Time PCR Assay for the Rapid Detection of Multiple Bacterial Antibiotic Resistance Genes Directly from Positive Blood Culture
【2h】

A Locked Nucleic Acid (LNA)-Based Real-Time PCR Assay for the Rapid Detection of Multiple Bacterial Antibiotic Resistance Genes Directly from Positive Blood Culture

机译:基于锁定核酸(LNA)的实时PCR分析方法可直接从阳性血液培养物中快速检测多种细菌耐药基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bacterial strains resistant to various antibiotic drugs are frequently encountered in clinical infections, and the rapid identification of drug-resistant strains is highly essential for clinical treatment. We developed a locked nucleic acid (LNA)-based quantitative real-time PCR (LNA-qPCR) method for the rapid detection of 13 antibiotic resistance genes and successfully used it to distinguish drug-resistant bacterial strains from positive blood culture samples. A sequence-specific primer-probe set was designed, and the specificity of the assays was assessed using 27 ATCC bacterial strains and 77 negative blood culture samples. No cross-reaction was identified among bacterial strains and in negative samples, indicating 100% specificity. The sensitivity of the assays was determined by spiking each bacterial strain into negative blood samples, and the detection limit was 1–10 colony forming units (CFU) per reaction. The LNA-qPCR assays were first applied to 72 clinical bacterial isolates for the identification of known drug resistance genes, and the results were verified by the direct sequencing of PCR products. Finally, the LNA-qPCR assays were used for the detection in 47 positive blood culture samples, 19 of which (40.4%) were positive for antibiotic resistance genes, showing 91.5% consistency with phenotypic susceptibility results. In conclusion, LNA-qPCR is a reliable method for the rapid detection of bacterial antibiotic resistance genes and can be used as a supplement to phenotypic susceptibility testing for the early detection of antimicrobial resistance to allow the selection of appropriate antimicrobial treatment and to prevent the spread of resistant isolates.
机译:在临床感染中经常遇到对各种抗生素药物具有抗性的细菌菌株,并且快速鉴定抗药性菌株对于临床治疗非常重要。我们开发了一种基于锁核酸(LNA)的定量实时PCR(LNA-qPCR)方法,用于快速检测13种抗生素抗性基因,并成功地将其用于从阳性血液培养样品中区分出耐药菌菌株。设计了序列特异性引物-探针组,并使用27个ATCC细菌菌株和77个阴性血液培养样品评估了测定的特异性。在细菌菌株之间和阴性样品中均未发现交叉反应,表明特异性为100%。通过将每个细菌菌株加标成阴性血样来确定测定的灵敏度,每个反应的检出限为1-10个菌落形成单位(CFU)。首先将LNA-qPCR分析应用于72种临床细菌分离株,以鉴定已知的耐药基因,并通过PCR产物的直接测序来验证结果。最后,LNA-qPCR检测用于47个阳性血液培养样品的检测,其中19个(40.4%)的抗生素抗性基因呈阳性,与表型敏感性结果显示91.5%的一致性。总之,LNA-qPCR是一种快速检测细菌抗生素抗性基因的可靠方法,可作为表型药敏试验的补充,用于早期检测抗药性,从而可以选择适当的抗微生物剂并防止扩散抗性分离株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号